Arrowhead Pharmaceuticals (ARWR) Insider Trading & Ownership $28.19 -0.75 (-2.59%) (As of 07/26/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Arrowhead Pharmaceuticals (NASDAQ:ARWR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage4.50%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$54,990.00Number OfInsiders Selling(Last 12 Months)8Amount OfInsider Selling(Last 12 Months)$10.41 M Get ARWR Insider Trade Alerts Want to know when executives and insiders are buying or selling Arrowhead Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ARWR Insider Buying and Selling by Quarter Ad DTIWe’re in a code red crisis and 99% of Americans are clueless Folks, it's 2024… Things that we used to rely on - are failing us. Take the phasing out of fossil fuels… Matched with the destruction of oil refineries around the world… And the outright failure of solar and wind technologies… But there is just one solution… And right now governments around the world are stockpiling this resource at the fastest rate in DECADES! And how YOU can prepare for the next 2024 BOOM here! Arrowhead Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/2/2024Tracie OliverInsiderSell9,394$25.28$237,480.32 5/2/2024Victoria VakienerDirectorSell1,799$23.31$41,934.69 3/20/2024Hongbo LuDirectorBuy1,000$27.50$27,500.00 3/18/2024Hongbo LuDirectorBuy1,000$27.49$27,490.00 3/6/2024Kenneth Allen MyszkowskiCFOSell40,000$35.19$1,407,600.00 1/31/2024Christopher Richard AnzaloneCEOSell57,499$32.35$1,860,092.65 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 1/12/2024James C HamiltonInsiderSell7,940$36.89$292,906.60 1/11/2024Douglas B GivenDirectorSell2,911$38.06$110,792.66 1/5/2024James C HamiltonInsiderSell32,143$35.18$1,130,790.74 1/5/2024Kenneth Allen MyszkowskiCFOSell16,104$35.27$567,988.08 1/5/2024Patrick O'brienCOOSell22,841$35.27$805,602.07 1/3/2024James C HamiltonInsiderSell6,300$32.19$202,797.00 1/3/2024Patrick O'brienCOOSell8,749$32.28$282,417.72 1/2/2024Christopher Richard AnzaloneCEOSell9,952$31.01$308,611.52 12/20/2023Christopher Richard AnzaloneCEOSell12,000$28.54$342,480.00 11/20/2023Martin Javier SanInsiderSell19,700$28.80$567,360.00 10/25/2023Christopher Richard AnzaloneCEOSell24,338$24.21$589,222.98 9/28/2023Victoria VakienerDirectorSell1,550$26.33$40,811.50 9/18/2023Christopher Richard AnzaloneCEOSell57,755$28.12$1,624,070.60 (Data available from 1/1/2013 forward) ARWR Insider Trading Activity - Frequently Asked Questions Who is on Arrowhead Pharmaceuticals's Insider Roster? The list of insiders at Arrowhead Pharmaceuticals includes Adeoye Y Olukotun, Christopher Richard Anzalone, Douglas B Given, Hongbo Lu, James C Hamilton, Kenneth Allen Myszkowski, Martin Javier San, Patrick O'brien, Tracie Oliver, Victoria Vakiener, and William D Waddill. Learn more on insiders at ARWR. What percentage of Arrowhead Pharmaceuticals stock is owned by insiders? 4.50% of Arrowhead Pharmaceuticals stock is owned by insiders. Learn more on ARWR's insider holdings. Which Arrowhead Pharmaceuticals insiders have been buying company stock? The following insider purchased ARWR shares in the last 24 months: Hongbo Lu ($54,990.00). How much insider buying is happening at Arrowhead Pharmaceuticals? Insiders have purchased a total of 2,000 ARWR shares in the last 24 months for a total of $54,990.00 bought. Which Arrowhead Pharmaceuticals insiders have been selling company stock? The following insiders have sold ARWR shares in the last 24 months: Adeoye Y Olukotun ($370,577.50), Christopher Richard Anzalone ($6,874,359.67), Douglas B Given ($405,185.16), James C Hamilton ($2,646,088.98), Kenneth Allen Myszkowski ($3,743,588.08), Martin Javier San ($1,152,165.00), Patrick O'brien ($2,319,644.79), Tracie Oliver ($552,622.07), Victoria Vakiener ($82,746.19), and William D Waddill ($96,000.00). How much insider selling is happening at Arrowhead Pharmaceuticals? Insiders have sold a total of 541,519 Arrowhead Pharmaceuticals shares in the last 24 months for a total of $18,242,977.44 sold. More Insider Trading Tools from MarketBeat Related Companies: Bausch Health Companies Insider Selling Sarepta Therapeutics Insider Selling Insmed Insider Selling Catalent Insider Selling Roivant Sciences Insider Selling Intra-Cellular Therapies Insider Selling Cerevel Therapeutics Insider Selling Blueprint Medicines Insider Selling Ionis Pharmaceuticals Insider Selling Jazz Pharmaceuticals Insider Selling Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: Insider Selling: When It Matters and When It Doesn'tInsiders Sell These Tech Stocks, but Investors Shouldn’tWhat Does Market Rotation Mean for This Top AI Stock?3 Beaten Down Stocks That Insiders Are Buying3 Insider-Buy Stocks to Add to Your Watchlist Now This page (NASDAQ:ARWR) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | SponsoredThe #1 Crypto for 2024 (3 Cent Coin)Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arrowhead Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Arrowhead Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.